BridgeBio Oncology Therapeutics (BBOT) Earnings Date & Reports

BridgeBio Oncology Therapeutics Inc, is a clinical-stage biotechnology company that aims to transform the lives of patients with cancers driven by RAS and PI3Ka, the two frequently mutated oncogenes... Show more

Get AI intraday signals

A.I. Advisor

published Earnings

BBOT is expected to report earnings to fall 99.92% to -56 cents per share on November 18

BridgeBio Oncology Therapeutics BBOT Stock Earnings Reports

Q3'26

Est.

$-0.57

Q2'26

Missed

by $704.68

Q1'26

Missed

by $0.06

Q4'25

Missed

by $0.07

The last earnings report on August 11 showed earnings per share of -70520 cents, missing the estimate of -51 cents. With 196.07K shares outstanding, the current market capitalization sits at 305.46M.

View a ticker or compare two or three

BBOT

Daily Signal:

Gain/Loss:

Interact to see
Advertisement

A.I.Advisor

published price charts

View AI-Driven Trading for BBOT